This month’s (March) patient meeting included a presentation by Endocrinology Specialist Nurses from Manchester Royal Infirmary. This was a talk we requested as we know secondary adrenal insufficiency is a concern for many patients.
Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory condition that occurs when the immune system overreacts to the Aspergillus fungus, leading to inflammation and potential lung damage. To manage the symptoms of ABPA, patients are often prescribed corticosteroid medications. However, long-term use of these medications can lead to a condition called secondary adrenal insufficiency. Watch the talk below to learn more about the condition, it’s diagnosis, management and treatment.
Share this post
Latest News posts
Aspergillosis Survivor Reaches the South Pole
February 15, 2019
A rough guide to health food supplements
February 15, 2019
Common herbs and their uses
February 15, 2019
One glass of red wine a day is good for us?
February 15, 2019
Winter coughs and colds – Practice good hygiene
February 15, 2019
Recognising the signs of too much stress
February 15, 2019
Media Food Facts: How true are they?
February 15, 2019
Travelling in a Wheelchair: A patient’s story
February 15, 2019
We Only Sing When We’re Wheezing!
February 15, 2019
Doctors need empathy
February 15, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video